{"name":"Rajesh Pahwa, MD","slug":"rajesh-pahwa-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Mirapex","genericName":"Mirapex","slug":"mirapex","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Requip PR","genericName":"Requip PR","slug":"requip-pr","indication":"Parkinson's disease","status":"phase_3"}]}],"pipeline":[{"name":"Mirapex","genericName":"Mirapex","slug":"mirapex","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Requip PR","genericName":"Requip PR","slug":"requip-pr","phase":"phase_3","mechanism":"Requip PR is a dopamine agonist that stimulates dopamine receptors in the brain to increase dopamine activity.","indications":["Parkinson's disease","Restless legs syndrome"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFByc1I3ZTU2ejI1eDIyVU1zU05iRkhURHZNeGVrRTFSV3NjQ29FTHlrQy1DNk8zWUY5Zk45d29aeGJjSnpwRjd6am9TVWxyRmluSlpRd0s1TDVMMzJacW5nQXRLeFdicWo3THF2MG1yNA?oc=5","date":"2025-07-02","type":"regulatory","source":"MedPage Today","summary":"FDA Clears AI-Powered Wearable for Essential Tremor - MedPage Today","headline":"FDA Clears AI-Powered Wearable for Essential Tremor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQNWl2bGFFNGVlLVdRTlVHMzVCN2cyYWN5N3JxdTlqUll2VkYtOXUyMWQ1UlpQUFVob3IxS2NwN3RLRlptcHVlak5zWHZ3TVUzMXIzZDJjal9IZ0wwdER4dUsyd2hSSXNNM3p1enBVRS1leS1WYmpoTC1MV1pwcV9XM2lmRlUxbW9MSkdFelI5dDJOa3NQdDNGa1R2MA?oc=5","date":"2025-04-16","type":"pipeline","source":"Parkinson's News Today","summary":"AAN 2025: Stable motor control seen with long-term ND0612 - Parkinson's News Today","headline":"AAN 2025: Stable motor control seen with long-term ND0612 - Parkinson's News Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE0tMWU4YjVaWXZtaERPM2I3VlVwdXdHNzctS01wVTU4aVk5RjY2ajVJWEdWYVVZQ09Hc1pMS2pONk1jZ25ycHdULTFaZU92dU5iUWtNR3ZKR2x2RTctems4MGZqQmpkUQ?oc=5","date":"2025-04-09","type":"pipeline","source":"MedPage Today","summary":"Wristband Nerve Stimulator Improves Essential Tremor Outcomes - MedPage Today","headline":"Wristband Nerve Stimulator Improves Essential Tremor Outcomes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQQ2hMUVdUSGJTQmNQOUNQM3QxU2M2WktKcDl1MUlMLUR1TEFYNEN2Z094Vm9vZWcwb0ZvZ1p0MlVRRndEOHVTd3dUV0JkVWFnOFpmdlQ5b3ZiSC1NaEpZd0ZaSllQcGZRUDZEdk1lWmVsdXRkYkV6NTFWX1VmNndKbWhXWTBFNHBWeHlmOG9ueVlvUXNYaFpxOWJXXzRlckF4NUVZLW5vemM?oc=5","date":"2025-04-08","type":"pipeline","source":"Healio","summary":"Felix NeuroAI wristband improves essential tremor outcomes - Healio","headline":"Felix NeuroAI wristband improves essential tremor outcomes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNT3A3XzgwVVAwTnVfd0tJQmQ5b3N4V0VERHF6SDNGa3lnaWRjVXRfUFBick1fd0pUd2JHeDNTcEV0enRXdDNWMVJTUXlhaUJHbzJWWHh4XzlZWXdnWWMxS01aakUycFdRMk1mcHdZSkJFbzQ5M3U0WUhyMG1fS1h3TnRpdDc2bmpqeXZ5TVlQeXYtQXZCd3B1VThzX2t3am9BMHh4d20zNFJQLVhVUmxHeFNDU05BUllVbS0tSG5B?oc=5","date":"2025-02-07","type":"regulatory","source":"Pharmaceutical Executive","summary":"FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease - Pharmaceutical Executive","headline":"FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOeUs3WVVsY1M0MTRnSV9Jdi03NFczX0pJX3A2cDk0YWMwRS11LW9ILTg4WDYyNDhjT2piZ2Q2RmY2b1RLRVptX2VKVU1xTFZCWFNDbVJXYThvU2xXelRJWWpxYUFvZTd2WmY3VlRDY3RqWV8tMVFTRGFpQ2M5QlZpTFoyNElQUQ?oc=5","date":"2023-10-21","type":"pipeline","source":"Psychiatrist.com","summary":"Pathophysiology, Patient Burden, and Recognition of OFF Episodes of Parkinson Disease - Psychiatrist.com","headline":"Pathophysiology, Patient Burden, and Recognition of OFF Episodes of Parkinson Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdXhmMDZvZXA5a0Y4dFRRQ1pSOFdPY3VVYVc2a3VhM3B3Zm85OEdZcElZNVRKYXFnUm4yZDhCLWR1TTdCMkliMzBXYWJJeE91RDAzRElFVWpPdWh0cGszbUVMWEw0WUtGdTBzaG9hejVQVTN1Z0NRRGkyZnRtVXctMzc4Tnh2Zk40?oc=5","date":"2022-05-18","type":"pipeline","source":"NeurologyLive","summary":"Role of Levodopa in Managing Parkinson Disease - NeurologyLive","headline":"Role of Levodopa in Managing Parkinson Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE42U0pCMVZQV2xjanY2VUxZR09LQnZSc1lPcWxLNzhHNmlLV2hGTEpHak5GSFBpV0trRGNZdTZ1UDlId0RHWHVYUkpGaC1LLThPb3hKazNR?oc=5","date":"2020-10-30","type":"pipeline","source":"Medscape","summary":"Sublingual Apomorphine Alleviates Parkinson's OFF Episodes - Medscape","headline":"Sublingual Apomorphine Alleviates Parkinson's OFF Episodes","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}